证券记录 · 已归档季度
DXCM
DexCom, Inc. · Healthcare · Medical - Devices
19被追踪持有人
-2Δ持有人
54.56M持有股份
$3.66B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -9.5% ·
股份流向 +3.0% ·
净新建仓位 -10.5%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 360.94K | $29.46M | n/a | −1 |
| Q2 2026 | 168 | +1 | 305.13M | $20.51B | +7 | −5 |
| Q1 2026 | 169 | 0 | 297.37M | $18.71B | +3 | −4 |
| Q4 2025 | 168 | 0 | 314.09M | $20.85B | +1 | n/a |
| Q3 2025 | 26 | +1 | 175.97M | $11.84B | +1 | −1 |
| Q2 2025 | 23 | -1 | 152.74M | $13.33B | n/a | −1 |
| Q1 2025 | 21 | 0 | 61.18M | $4.17B | n/a | n/a |
| Q4 2024 | 21 | +1 | 69.06M | $5.37B | +1 | n/a |
| Q3 2024 | 19 | -2 | 54.56M | $3.66B | n/a | −2 |
| Q2 2024 | 21 | n/a | 52.99M | $6.01B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 15.02M | -2.0% | $1.01B | 0.8% | ▼ Trim | 2 | SEC ↗ ×4 |
| 2 | Geode Capital Management ✦ (被动) | 9.94M | +2.2% | $664.06M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Capital World Investors ✦ | 7.63M | -8.2% | $511.36M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 5.70M | +6.9% | $382.03M | 0.1% | ▲ Add | 2 | SEC ↗ ×12 |
| 5 | Norges Bank ✦ (被动) | 5.00M | -7.2% | $335.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 3.22M | -6.8% | $215.54M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 2.43M | +6697.8% | $162.88M | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 1.23M | +69.5% | $82.72M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 856.12K | +10.6% | $57.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 830.97K | +79.6% | $55.71M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 825.00K | +9.7% | $55.31M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 547.95K | +40.9% | $36.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 341.64K | +429.8% | $22.90M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 14 | Bridgewater Associates ✦ | 319.63K | -8.0% | $21.43M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 264.00K | -24.9% | $17.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 197.29K | +132.1% | $13.23M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 17 | Arrowstreet Capital ✦ | 81.42K | +48.1% | $5.46M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 78.80K | +64.6% | $5.28M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 52.00K | 0.0% | $3.49M | 0.0% | Held | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Tiger Global Management | $130.71M | 曾为 0.6% |
| Soros Fund Management | $18.91M | 曾为 0.6% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 15.50K 股份, $973 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 28
Stern Sadie
Officer · 2.56K 股 · $220,975
Sep 15
AUGUSTINOS NICHOLAS
Director · 6.54K 股 · $549,538
Sep 15
Brown Michael Jon
Officer · 1.70K 股 · $142,868
Sep 14
AUGUSTINOS NICHOLAS
Director · 1.55K 股 · $130,231
Sep 10
Sylvain Jereme M
Officer · 3.64K 股 · $302,936
Aug 27
Stern Sadie
Officer · 2.56K 股 · $226,669
Aug 20
SAYER KEVIN R
Officer, Director · 19.31K 股 · $1.73M
Aug 20
SAYER KEVIN R
Officer, Director · 97 股 · $8,867
Aug 20
SAYER KEVIN R
Officer, Director · 7.35K 股 · $667,332
Aug 14
Brown Michael Jon
Officer · 1.70K 股 · $156,281
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据